MMS, an award-winning, data-focused clinical research organization (CRO), announces its acquisition of Exploristics, a leading biostatistics and data science company based in Belfast, Northern Ireland. The acquisition will add the company’s flagship product, KerusCloud®, a state-of-the-art, cloud-based statistical modeling and simulation platform to MMS’ data-driven approach towards efficient drug development. With a history of strong organic growth, the acquisition of Exploristics positions MMS to enhance its global footprint and capabilities in advanced clinical trial design, innovative statistics, and data science.
Read the full article: MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO //
Source: https://www.businesswire.com/news/home/20250212678720/en/MMS-Acquires-Exploristics-and-KerusCloud-Simulation-Platform-to-Expand-Biostatistics-and-Data-Science-Capabilities-as-a-Global-Data-Focused-CRO